Difference between revisions of "Amniotic fluid embolism"

From WikiAnesthesia
(started)
 
 
(3 intermediate revisions by the same user not shown)
Line 10: Line 10:
}}
}}


An amniotic fluid embolism is a rare but serious condition with high morbidity and mortality.  
An amniotic fluid embolism (AFE) is a rare but serious condition with high morbidity and mortality. It is characterized by cardiopulmonary collapse and disseminated intravascular coagulation (DIC). It is the second-leading cause of peripartum maternal death in the US and number one cause of peripartum cardiac arrest. <ref>{{Citation|last=Haftel|first=Anthony|title=Amniotic Fluid Embolism|date=2022|url=http://www.ncbi.nlm.nih.gov/books/NBK559107/|work=StatPearls|place=Treasure Island (FL)|publisher=StatPearls Publishing|pmid=32644533|access-date=2022-10-20|last2=Chowdhury|first2=Yuvraj S.}}</ref>
 
== Risk Factors<!-- List and briefly describe any procedures which may be performed specifically to treat this comorbidity or its sequelae. If none, this section may be removed. -->==
== Anesthetic implications<!-- Briefly summarize the anesthetic implications of this comorbidity. --> ==
Risk factors for the development of AFE are advanced maternal age, multiparity, male fetuses, and trauma. Induction of labor has also been found to increase risk for AFE. 
 
=== Preoperative optimization<!-- Describe how this comorbidity may influence preoperative evaluation and optimization of patients. --> ===
 
=== Intraoperative management<!-- Describe how this comorbidity may influence intraoperative management. --> ===
 
=== Postoperative management<!-- Describe how this comorbidity may influence postoperative management. --> ===
 
== Related surgical procedures<!-- List and briefly describe any procedures which may be performed specifically to treat this comorbidity or its sequelae. If none, this section may be removed. --> ==


== Pathophysiology<!-- Describe the pathophysiology of this comorbidity. Add subsections as needed. --> ==
== Pathophysiology<!-- Describe the pathophysiology of this comorbidity. Add subsections as needed. --> ==
AFE is poorly understood. It is thought to originate from a disruption of the placenta-amniotic interface with the subsequent entry of amniotic fluid and fetal elements (such as hair, meconium, squama, and mucin) into the maternal circulation. Upon entering the pulmonary tree, intense pulmonary vasoconstriction occurs. This may be associated with concomitant bronchoconstriction. The hemodynamic result is acute pulmonary arterial obstruction, dilatation of the right ventricle and the right atrium, and significant tricuspid regurgitation. The right ventricular enlargement causes the intraventricular septum to bow into the left ventricle creating obstruction and systolic dysfunction, further raising pulmonary artery pressure and decreasing cardiac output. Hypoxemia and hypotension lead to sudden cardiovascular collapse. 


== Signs and symptoms<!-- Describe the signs and symptoms of this comorbidity. --> ==
Normally, pregnancies are procoagulant, to begin with, and the introduction of amniotic fluid and fetal elements trigger inflammatory mediators activating the coagulation cascade and fibrinolytic systems resulting in DIC.


== Diagnosis<!-- Describe how this comorbidity is diagnosed. --> ==
== Diagnosis<!-- Describe how this comorbidity is diagnosed. --> ==
The American Society for Maternal-Fetal Medicine, after a consensus symposium has created its criteria for AFE, which require the following:


== Treatment<!-- Summarize the treatment of this comorbidity. Add subsections as needed. --> ==
# Sudden cardiopulmonary collapse, or hypotension (systolic blood pressure less than 90 mmHg) with hypoxia (SpO2 less than 90%)
 
# DIC, according to the international society on thrombosis and hemostasis (ISTH) definition
=== Medication<!-- Describe medications used to manage this comorbidity. --> ===
# Symptomatology either during labor or during placental delivery (or up to 30 minutes later)
 
# No fever
=== Surgery<!-- Describe surgical procedures used to treat this comorbidity. --> ===


=== Prognosis<!-- Describe the prognosis of this comorbidity --> ===
== Management<!-- Summarize the treatment of this comorbidity. Add subsections as needed. -->==
The cornerstone of AFE management is prompt cardiopulmonary resuscitation of the mother with rapid evacuation of the fetus.


== Epidemiology<!-- Describe the epidemiology of this comorbidity --> ==
For the mother, this includes securing the airway, effective ventilation, pressors as appropriate, and fluid management. After intubation, large bore intravascular access should be obtained for resuscitation.


== References ==
== References ==


[[Category:Comorbidities]]
[[Category:Comorbidities]]

Latest revision as of 13:38, 24 October 2022

Amniotic fluid embolism
Anesthetic relevance
Anesthetic management

{{{anesthetic_management}}}

Specialty
Signs and symptoms
Diagnosis
Treatment
Article quality
Editor rating
In development
User likes
0

An amniotic fluid embolism (AFE) is a rare but serious condition with high morbidity and mortality. It is characterized by cardiopulmonary collapse and disseminated intravascular coagulation (DIC). It is the second-leading cause of peripartum maternal death in the US and number one cause of peripartum cardiac arrest. [1]

Risk Factors

Risk factors for the development of AFE are advanced maternal age, multiparity, male fetuses, and trauma. Induction of labor has also been found to increase risk for AFE.

Pathophysiology

AFE is poorly understood. It is thought to originate from a disruption of the placenta-amniotic interface with the subsequent entry of amniotic fluid and fetal elements (such as hair, meconium, squama, and mucin) into the maternal circulation. Upon entering the pulmonary tree, intense pulmonary vasoconstriction occurs. This may be associated with concomitant bronchoconstriction. The hemodynamic result is acute pulmonary arterial obstruction, dilatation of the right ventricle and the right atrium, and significant tricuspid regurgitation. The right ventricular enlargement causes the intraventricular septum to bow into the left ventricle creating obstruction and systolic dysfunction, further raising pulmonary artery pressure and decreasing cardiac output. Hypoxemia and hypotension lead to sudden cardiovascular collapse.

Normally, pregnancies are procoagulant, to begin with, and the introduction of amniotic fluid and fetal elements trigger inflammatory mediators activating the coagulation cascade and fibrinolytic systems resulting in DIC.

Diagnosis

The American Society for Maternal-Fetal Medicine, after a consensus symposium has created its criteria for AFE, which require the following:

  1. Sudden cardiopulmonary collapse, or hypotension (systolic blood pressure less than 90 mmHg) with hypoxia (SpO2 less than 90%)
  2. DIC, according to the international society on thrombosis and hemostasis (ISTH) definition
  3. Symptomatology either during labor or during placental delivery (or up to 30 minutes later)
  4. No fever

Management

The cornerstone of AFE management is prompt cardiopulmonary resuscitation of the mother with rapid evacuation of the fetus.

For the mother, this includes securing the airway, effective ventilation, pressors as appropriate, and fluid management. After intubation, large bore intravascular access should be obtained for resuscitation.

References

  1. Haftel, Anthony; Chowdhury, Yuvraj S. (2022), "Amniotic Fluid Embolism", StatPearls, Treasure Island (FL): StatPearls Publishing, PMID 32644533, retrieved 2022-10-20